DENTSPLY SIRONA Inc. (XRAY) Earnings History
Net Loss40 years of earnings data (1986–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
DENTSPLY SIRONA Inc. (XRAY) Earnings Overview
As of June 22, 2026, DENTSPLY SIRONA Inc. (XRAY) reported trailing twelve-month net income of -$628M, reflecting +33.0% year-over-year growth. The company earned $-3.14 per diluted share over the past four quarters, with a net profit margin of -16.3%.
Looking at the long-term picture, XRAY's historical earnings data spans multiple years. The company achieved its highest annual net income of $430M in fiscal 2016.
DENTSPLY SIRONA Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ALGN ($430M net income, 10.2% margin), HSIC ($398M net income, 3.0% margin), NVST ($68M net income, 1.7% margin), XRAY has room to improve margins relative to the peer group. Compare XRAY vs ALGN →
XRAY Earnings vs Peers
Earnings metrics vs comparable public companies
XRAY Historical Earnings Data (1986–2025)
36 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$598M | +34.3% | $252M | $-3.00 | -16.3% | 6.8% |
| 2024 | -$910M | -589.4% | -$879M | $-4.48 | -24.0% | -23.2% |
| 2023 | -$132M | +86.1% | -$85M | $-0.62 | -3.3% | -2.1% |
| 2022 | -$950M | -331.1% | -$937M | $-4.41 | -24.2% | -23.9% |
| 2021 | $411M | +663.0% | $608M | $1.87 | 9.7% | 14.4% |
| 2020 | -$73M | -128.5% | -$3M | $-0.38 | -2.2% | -0.1% |
| 2019 | $256M | +125.3% | $353M | $1.17 | 6.4% | 8.8% |
| 2018 | -$1.01B | +34.8% | -$958M | $-4.51 | -25.4% | -24.0% |
| 2017 | -$1.55B | -460.5% | -$1.59B | $-6.86 | -38.8% | -39.7% |
| 2016 | $430M | +71.1% | $455M | $1.94 | 11.5% | 12.1% |
| 2015 | $251M | -22.2% | $375M | $1.76 | 9.4% | 14.0% |
| 2014 | $323M | +3.1% | $446M | $2.24 | 11.0% | 15.2% |
| 2013 | $313M | -0.3% | $419M | $2.16 | 10.6% | 14.2% |
| 2012 | $314M | +28.5% | $382M | $2.18 | 10.7% | 13.0% |
| 2011 | $245M | -8.0% | $301M | $1.70 | 9.6% | 11.9% |
| 2010 | $266M | -3.1% | $380M | $1.82 | 12.0% | 17.1% |
| 2009 | $274M | -3.4% | $381M | $1.83 | 12.7% | 17.6% |
| 2008 | $284M | +9.3% | $380M | $1.87 | 12.9% | 17.3% |
| 2007 | $260M | +16.1% | $355M | $1.68 | 12.9% | 17.7% |
| 2006 | $224M | +392.6% | $315M | $1.41 | 12.4% | 17.4% |
| 2005 | $45M | -82.1% | $73M | $0.28 | 2.6% | 4.3% |
| 2004 | $253M | +45.3% | $295M | $1.55 | 14.9% | 17.4% |
| 2003 | $174M | +17.7% | $268M | $1.09 | 11.1% | 17.1% |
| 2002 | $148M | +21.8% | $257M | $0.93 | 9.8% | 16.9% |
| 2001 | $121M | +20.3% | $178M | $0.77 | 10.8% | 15.8% |
| 2000 | $101M | +12.4% | $164M | $0.65 | 11.4% | 18.4% |
| 1999 | $90M | +158.3% | $150M | $0.56 | 10.8% | 18.0% |
| 1998 | $35M | -53.4% | $141M | $0.22 | 4.4% | 17.8% |
| 1997 | $75M | +11.0% | $133M | $0.46 | 10.3% | 18.4% |
| 1996 | $67M | +24.4% | $120M | $0.42 | 10.2% | 18.2% |
| 1995 | $54M | -12.9% | $101M | $0.33 | 9.4% | 17.6% |
| 1994 | $62M | +339.7% | $98M | $0.37 | 11.8% | 18.6% |
| 1993 | $14M | +166.0% | $79M | $0.09 | 2.6% | 14.3% |
| 1992 | $5M | +82.8% | $13M | $0.10 | 6.3% | 14.9% |
| 1990 | $3M | +262.5% | $8M | $0.07 | 5.3% | 14.5% |
| 1986 | $800,000 | - | $1M | $0.02 | 6.3% | 11.0% |
Download Data
Export XRAY earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
40+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
XRAY — Frequently Asked Questions
Quick answers to the most common questions about buying XRAY stock.
What is XRAY earnings per share (EPS)?
XRAY trailing twelve-month (TTM) diluted EPS is $-3.14, reflecting +33.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1986 to 2025 is available in the table on this page.
What is DENTSPLY SIRONA Inc.'s net income?
DENTSPLY SIRONA Inc. (XRAY) trailing twelve-month net income is $-628M as of 2025. Earnings grew +33.0% year-over-year.
Is XRAY profitable?
XRAY is not currently profitable on a TTM basis, reporting a net loss of $-628M. Net margin is -16.3%. Investors should monitor for a return to profitability.
What is XRAY's earnings growth rate?
XRAY compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1986 to 2025.
What are XRAY's profit margins?
DENTSPLY SIRONA Inc. net profit margin is -16.3%, operating margin is +6.8%, and gross margin is +50.0%. Below-average margins reflect competitive or cost pressures. Return on Equity is -36.4%.
Is XRAY growing earnings?
Yes, XRAY earnings are accelerating — EPS growth of +33.0% exceeds the 5-year CAGR of N/A. TTM net income reached $-628M. Earnings momentum is strengthening.
What was XRAY's best earnings year?
DENTSPLY SIRONA Inc.'s highest annual net income on record is $430M, achieved in fiscal year 2016. Earnings history on this page spans 1986 to 2025 and includes all annual and quarterly figures.
What were XRAY's earnings last quarter?
XRAY's most recent reported quarter was Q1 2026. Net income was $-10M with diluted EPS of $-0.05. For a full breakdown of all quarters, see the quarterly earnings table on this page.